StonvexLoading…
StonvexStonvexStonvexCore line items from YCBD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $10.66M | $5.02M | $19.19M | $14.47M |
Operating Income | $-1.09M | $-286.29K | $-2.16M | $-1.48M |
Net Income | $-1.08M | $-283.13K | $-2.04M | $-1.36M |
EPS (Diluted) | $-0.12 | $-0.04 | $-1.09 | $-1.56 |
Total Assets | $12.25M | $11.78M | $10.42M | $9.90M |
Total Liabilities | $2.97M | $2.77M | $3.19M | $3.78M |
Cash & Equivalents | $2.64M | $3.39M | $2.26M | $1.06M |
Free Cash Flow OCF − CapEx | $-1.71M | $-977.27K | $-1.64M | $-1.39M |
Shares Outstanding | 10.50M | 10.07M | 8.92M | 8.91M |